The appropriate pharmacological management of recent-onset schizophrenia: an international panel study using the RAND/UCLA methodology
John M. Kane(University of North Carolina at Chapel Hill), Herman Stoevelaar(Barnes-Jewish Hospital), Philip Gorwood(Inserm), R. D. NEWTON, Peter Haddad(Deakin University), Celso Arango(Hospital Universitario La Paz), Ofer Agid(Centre for Addiction and Mental Health), C. Correll, Wiepke Cahn(University Medical Center Utrecht), Stephan Heres(München Klinik), Richard Emsley(University of Manchester), Mike Lambert(University of Southern Queensland)
Cited by 0
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
|Nature Reviews Drug Discovery|2012|1.3k
The consequences of the COVID-19 pandemic on mental health and implications for clinical practice
|European Psychiatry|2020|1.2k
Schizophrenia
|Nature Reviews Disease Primers|2015|1.1k